Abstract
Purpose
Bardet-Biedl syndrome (BBS) is a rare autosomal recessive disorder characterized by retinal dystrophy, renal dysfunction, central obesity, mental impairment, polydactyly, and hypogonadism. Only limited information on BBS is available from Japanese patients. In addition, there are currently no reports of Japanese patients with BBS caused by BBS10 mutations. The purpose of this study was to present the characteristics of a Japanese patient with BBS caused by BBS10 mutations.
Patient and methods
The patient was a 22-year-old Japanese woman. Comprehensive ophthalmic examinations, including visual acuity measurements, perimetry, electroretinography (ERG), fundus autofluorescence imaging, and optical coherence tomography, were performed. Trio-based whole-exome sequencing was performed to identify potential pathogenic mutations, confirmed by Sanger sequencing.
Results
The patient showed neither renal malformation nor dysfunction, and visual impairment seemed to be relatively mild for BBS. The fundus examination revealed diffuse retinal degeneration without pigmentary deposits, and ERG scans showed undetectable responses. She had a history of surgically corrected polydactyly, and displayed symptoms of obesity. There was also a menstrual irregularity that could require progestin administration. Genetic analysis revealed compound heterozygous BBS10 mutations in the patient: a novel missense mutation c.98G>A [p.(G33E)], and a novel nonsense mutation c.2125A>T [p.(R709*)].
Conclusion
To our knowledge, this is the first description of a Japanese patient with BBS caused by BBS10 mutations. The clinical characteristics of our patient were mild, as neither renal impairment nor legal blindness was observed. Early diagnosis would play a role in providing counseling, and in some cases, therapeutic interventions for BBS patients.
Similar content being viewed by others
References
Beales PL, Elcioglu N, Woolf AS, Parker D, Flinter FA. New criteria for improved diagnosis of Bardet–Biedl syndrome: results of a population survey. J Med Genet. 1999;36:437–46.
Esposito G, Testa F, Zacchia M, Crispo AA, Di Iorio V, Capolongo G, et al. Genetic characterization of Italian patients with Bardet–Biedl syndrome and correlation to ocular, renal and audio-vestibular phenotype: identification of eleven novel pathogenic sequence variants. BMC Med Genet. 2017;18:10.
Klein D, Ammann F. The syndrome of Laurence–Moon–Bardet–Biedl and allied diseases in Switzerland. Clinical, genetic and epidemiological studies. J Neurol Sci. 1969;9:479–513.
Daiger SD, Sullivan LS, Bowne SJ. The Retinal Information Network. The University of Texas Health Science Center, USA. http://www.sph.uth.tmc.edu/Retnet/. Accessed 27 Apr 2017.
Zaghloul NA, Katsanis N. Mechanistic insights into Bardet–Biedl syndrome, a model ciliopathy. J Clin Investig. 2009;119:428–37.
Muller J, Stoetzel C, Vincent MC, Leitch CC, Laurier V, Danse JM, et al. Identification of 28 novel mutations in the Bardet–Biedl syndrome genes: the burden of private mutations in an extensively heterogeneous disease. Hum Genet. 2010;127:583–93.
Stoetzel C, Laurier V, Davis EE, Muller J, Rix S, Badano JL, et al. BBS10 encodes a vertebrate-specific chaperonin-like protein and is a major BBS locus. Nature. 2006;38:521–4.
Billingsley G, Bin J, Fieggen KJ, Duncan JL, Gerth C, Ogata K, et al. Mutations in chaperonin-like BBS genes are a major contributor to disease development in a multiethnic Bardet–Biedl syndrome patient population. J Med Genet. 2010;47:453–63.
M’hamdi O, Ouertani I, Maazoul F, Chaabouni-Bouhamed H. Prevalence of Bardet–Biedl syndrome in Tunisia. J Community Genet. 2011;2:97–9.
Farag TI, Teebi AS. Bardet–Biedl and Laurence–Moon syndromes in a mixed Arab population. Clin Genet. 1988;33:78–82.
Hjortshøj TD, Grønskov K, Philp AR, Nishimura DY, Riise R, Sheffield VC, et al. Bardet–Biedl syndrome in Denmark—report of 13 novel sequence variations in six genes. Hum Mutat. 2010;31:429–36.
Woods MO, Young TL, Parfrey PS, Hefferton D, Green JS, Davidson WS. Genetic heterogeneity of Bardet–Biedl syndrome in a distinct Canadian population: evidence for a fifth locus. Genomics. 1999;55:2–9.
Nakamura F, Sasaki H, Kajihara H, Yamanoue M. Laurence–Moon–Biedl syndrome accompanied by congenital hepatic fibrosis. J Gastroenterol Hepatol. 1990;5:206–10.
Yamada K, Miura M, Miyayama H, Sakashita N, Kochi M, Ushio Y. Diffuse brainstem glioma in a patient with Laurence–Moon–(Bardet–)Biedl syndrome. Pediatr Neurosurg. 2000;33:323–7.
Tonomura Y, Hirano M, Shimada K, Asai H, Ikeda M, Kataoka H, et al. Treatable fluctuating mental impairment in a patient with Bardet–Biedl syndrome. Clin Neurol Neurosurg. 2009;111:102–4.
Hirano M, Ohishi M, Yamashita T, Ikuno Y, Iwahashi H, Mano T, et al. Abnormal cystatin C levels in two patients with Bardet–Biedl syndrome. Clin Med Insights Case Rep. 2011;4:17–20.
Saida K, Inaba Y, Hirano M, Satake W, Toda T, Suzuki Y, et al. A case of Bardet–Biedl syndrome complicated with intracranial hypertension in a Japanese child. Brain Dev. 2014;36:721–4.
Hirano M, Satake W, Ihara K, Tsuge I, Kondo S, Saida K, et al. The first nationwide survey and genetic analyses of Bardet–Biedl syndrome in Japan. PLoS One. 2015;10:e0136317.
Marmor MF, Fulton AB, Holder GE, Miyake Y, Brigell M, Bach M. ISCEV Standard for full-field clinical electroretinography (2008 update). Doc Ophthalmol. 2009;118:69–77.
Li H. Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM. 2013. arXiv:1303.3997v2. Preprint at http://arxiv.org/pdf/1303.3997.pdf.
McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A. The genome analysis toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 2010;20:1297–303.
Wang K, Li M, Hakonarson H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 2010;38:e164.
The 1000 Genomes Project data. In: The 1000 Genomes Project Consortium. http://www.1000genomes.org/. Accessed 27 Apr 2017.
ExAC database. In: The Exome Aggregation Consortium. http://exac.broadinstitute.org/. Accessed 27 Apr 2017.
Higasa K, Miyake N, Yoshimura J. Human genetic variation database. Kyoto University, Japan. http://www.genome.med.kyoto-u.ac.jp/SnpDB/. Accessed 27 Apr 2017.
Integrative Japanese Genome Variation Database. Tohoku University, Japan. https://ijgvd.megabank.tohoku.ac.jp/. Accessed 27 Apr 2017.
The Human Gene Mutation Database. Institute of Medical Genetics in Cardiff. http://www.hgmd.cf.ac.uk/ac/index.php. Accessed 27 Apr 2017.
Katagiri S, Akahori M, Sergeev Y, Yoshitake K, Ikeo K, Furuno M, et al. Whole exome analysis identifies frequent CNGA1 mutations in Japanese population with autosomal recessive retinitis pigmentosa. PLoS One. 2014;9:e108721.
Hosono K, Harada Y, Kurata K, Hikoya A, Sato M, Minoshima S, et al. Novel GUCY2D gene mutations in Japanese male twins with Leber congenital amaurosis. J Ophthalmol. 2015;693468. https://doi.org/10.1155/2015/693468.
Miyamichi D, Asahina M, Nakajima J, Sato M, Hosono K, Nomura T, et al. Novel HPS6 mutations identified by whole-exome sequencing in two Japanese sisters with suspected ocular albinism. J Hum Genet. 2016;61:839–42.
Sorting Tolerant From Intolerant. In: J. Craig Venter Institute. http://sift.jcvi.org/www/SIFT_seq_submit2.html. Accessed 27 Apr 2017.
Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, et al. A method and server for predicting damaging missense mutations. Nat Methods. 2010;7:248–9.
Schwarz JM, Cooper DN, Schuelke M, Seelow D. MutationTaster2: mutation prediction for the deep-sequencing age. Nat Methods. 2014;11:361–2.
Hosono K, Ishigami C, Takahashi M, Park DH, Hirami Y, Nakanishi H, et al. Two novel mutations in the EYS gene are possible major causes of autosomal recessive retinitis pigmentosa in the Japanese population. PLoS One. 2012;7:e31036.
Hosono K, Sasaki T, Minoshima S, Shimizu N. Identification and characterization of a novel gene family YPEL in a wide spectrum of eukaryotic species. Gene. 2004;340:31–43.
NCBI Reference Sequence Database. In: National Center for Biotechnology Information, USA. https://www.ncbi.nlm.nih.gov/refseq/. Accessed 27 Apr 2017.
Scheidecker S, Hull S, Perdomo Y, Studer F, Pelletier V, Muller J, et al. Predominantly cone-system dysfunction as rare form of retinal degeneration in patients with molecularly confirmed Bardet–Biedl syndrome. Am J Ophthalmol. 2015;160:364–72.
Hentze MW, Kulozik AE. A perfect message: RNA surveillance and nonsense-mediated decay. Cell. 1999;96:307–10.
Chang YF, Imam JS, Wilkinson MF. The nonsense-mediated decay RNA surveillance pathway. Annu Rev Biochem. 2007;76:51–74.
Agha Z, Iqbal Z, Azam M, Hoefsloot LH, van Bokhoven H, Qamar R. A novel homozygous 10 nucleotide deletion in BBS10 causes Bardet–Biedl syndrome in a Pakistani family. Gene. 2013;519:177–81.
Gerth C, Zawadzki RJ, Werner JS, Héon E. Retinal morphology in patients with BBS1 and BBS10 related Bardet–Biedl syndrome evaluated by Fourier-domain optical coherence tomography. Vis Res. 2008;48:392–9.
Tica I, Tica OS, Nicoară AD, Tica VI, Tica AA. Ovarian teratomas in a patient with Bardet–Biedl syndrome, a rare association. Romanian J Morphol Embryol. 2016;57:1403–8.
Simons DL, Boye SL, Hauswirth WW, Wu SM. Gene therapy prevents photoreceptor death and preserves retinal function in a Bardet–Biedl syndrome mouse model. Proc Natl Acad Sci USA. 2011;108:6276–81.
Seo S, Mullins RF, Dumitrescu AV, Bhattarai S, Gratie D, Wang K, et al. Subretinal gene therapy of mice with Bardet–Biedl syndrome type 1. Invest Ophthalmol Vis Sci. 2013;54:6118–32.
Acknowledgements
The authors would like to thank Editage (https://www.editage.jp/) for English language editing. This work was supported by a Grant from the Initiative on Rare and Undiagnosed Diseases for Adults (no. 16ek0109151h0002) from the Japan Agency for Medical Research and Development (AMED), and the Japan Society for the Promotion of Science Grant-in-Aid for Scientific Research (no. 26462659 awarded to Y. H. and no. 16K11284 awarded to K. H.).
Conflicts of interest
K. Kurata, None; K. Hosono, None; A. Hikoya, None; A. Kato, None; H. Saitsu, None; S. Minoshima, None; T. Ogata, None; Y. Hotta, None.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
About this article
Cite this article
Kurata, K., Hosono, K., Hikoya, A. et al. Clinical characteristics of a Japanese patient with Bardet-Biedl syndrome caused by BBS10 mutations. Jpn J Ophthalmol 62, 458–466 (2018). https://doi.org/10.1007/s10384-018-0591-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10384-018-0591-8